HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- January 09, 2007 -- Applied Spectrum Technologies, Inc. (OTCBB: APSP) (to be known as Benda Pharmaceutical, Inc. [the "Company" or "Benda"]) a Chinese-based pharmaceutical company engaged in the development, manufacturing and distribution of medicines, active pharmaceutical ingredients and pharmaceutical intermediaries, announced today that on December 29, 2006, the Company filed a Definitive 14C Information Statement with the Securities and Exchange Commission. Following the mandatory 20-day waiting period, the Definitive 14C Information Statement will become effective on January 18, 2007.
